Published in Proc Natl Acad Sci U S A on February 06, 1996
The adenosine kinase hypothesis of epileptogenesis. Prog Neurobiol (2007) 1.72
Adenosine kinase: exploitation for therapeutic gain. Pharmacol Rev (2013) 1.26
Adenosine kinase of Arabidopsis. Kinetic properties and gene expression. Plant Physiol (2000) 1.18
Purine pathway implicated in mechanism of resistance to aspirin therapy: pharmacometabolomics-informed pharmacogenomics. Clin Pharmacol Ther (2013) 1.10
Genome-wide mutagenesis of Xanthomonas axonopodis pv. citri reveals novel genetic determinants and regulation mechanisms of biofilm formation. PLoS One (2011) 1.07
Pain and Poppies: The Good, the Bad, and the Ugly of Opioid Analgesics. J Neurosci (2015) 1.03
Plasmodium falciparum purine nucleoside phosphorylase is critical for viability of malaria parasites. J Biol Chem (2008) 1.01
Identification and characterization of a unique adenosine kinase from Mycobacterium tuberculosis. J Bacteriol (2003) 0.95
Coupling of CFTR-mediated anion secretion to nucleoside transporters and adenosine homeostasis in Calu-3 cells. J Membr Biol (2003) 0.87
Phosphorylation of ribavirin and viramidine by adenosine kinase and cytosolic 5'-nucleotidase II: Implications for ribavirin metabolism in erythrocytes. Antimicrob Agents Chemother (2005) 0.86
Molecular cloning and expression of adenosine kinase from Leishmania donovani: identification of unconventional P-loop motif. Biochem J (1999) 0.85
An emerging role for adenosine and its receptors in bone homeostasis. Front Endocrinol (Lausanne) (2012) 0.85
Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics. Br J Pharmacol (2016) 0.84
A high-affinity adenosine kinase from Anopheles gambiae. Biochemistry (2011) 0.84
Crystal structure of adenosine kinase from Toxoplasma gondii at 1.8 A resolution. Protein Sci (2000) 0.83
Overexpression, purification and crystallographic analysis of a unique adenosine kinase from Mycobacterium tuberculosis. Acta Crystallogr Sect F Struct Biol Cryst Commun (2005) 0.81
Mutational analysis of the active-site residues crucial for catalytic activity of adenosine kinase from Leishmania donovani. Biochem J (2005) 0.81
Structure-activity relationship for adenosine kinase from Mycobacterium tuberculosis II. Modifications to the ribofuranosyl moiety. Biochem Pharmacol (2008) 0.78
Molecular characterization of Chinese hamster cells mutants affected in adenosine kinase and showing novel genetic and biochemical characteristics. BMC Biochem (2011) 0.77
An adenosine kinase exists in Xanthomonas campestris pathovar campestris and is involved in extracellular polysaccharide production, cell motility, and virulence. J Bacteriol (2009) 0.77
Adenosine A2B Receptor: From Cell Biology to Human Diseases. Front Chem (2016) 0.76
Molecular cloning and transcriptional analysis of a guanosine kinase gene of Brevibacterium acetylicum ATCC 953. J Bacteriol (1997) 0.75
Molecular Shape Analysis-Guided Virtual Screening Platform for Adenosine Kinase Inhibitors. Bioinform Biol Insights (2016) 0.75
Structural and functional roles of Cys-238 and Cys-295 in Escherichia coli phosphofructokinase-2. Biochem J (2003) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Basic local alignment search tool. J Mol Biol (1990) 659.07
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
The P-loop--a common motif in ATP- and GTP-binding proteins. Trends Biochem Sci (1990) 14.55
Convergent evolution of similar enzymatic function on different protein folds: the hexokinase, ribokinase, and galactokinase families of sugar kinases. Protein Sci (1993) 3.25
The functions and consensus motifs of nine types of peptide segments that form different types of nucleotide-binding sites. Eur J Biochem (1994) 2.94
Analysis of the Escherichia coli genome. V. DNA sequence of the region from 76.0 to 81.5 minutes. Nucleic Acids Res (1994) 2.92
Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s). Proc Natl Acad Sci U S A (1977) 2.90
The role of adenosine and 2'-deoxyadenosine in mammalian cells. Annu Rev Biochem (1978) 2.49
The cardiac effects of adenosine. Prog Cardiovasc Dis (1989) 2.20
Human thymidine kinase gene: molecular cloning and nucleotide sequence of a cDNA expressible in mammalian cells. Mol Cell Biol (1984) 1.96
Adenosine; a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils. J Immunol (1985) 1.96
Deoxyadenosine metabolism and cytotoxicity in cultured mouse T lymphoma cells: a model for immunodeficiency disease. Cell (1978) 1.78
Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci U S A (1991) 1.61
Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs. Biochem Biophys Res Commun (1991) 1.44
The complete sequence of the 8.2 kb segment left of MAT on chromosome III reveals five ORFs, including a gene for a yeast ribokinase. Yeast (1991) 1.41
Effects of mutational loss of adenosine kinase and deoxycytidine kinase on deoxyATP accumulation and deoxyadenosine toxicity in cultured CEM human T-lymphoblastoid cells. J Biol Chem (1982) 1.39
Ribokinase from Escherichia coli K12. Nucleotide sequence and overexpression of the rbsK gene and purification of ribokinase. J Biol Chem (1986) 1.39
Cardiac electrophysiology of adenosine. Basic and clinical concepts. Circulation (1991) 1.38
Adenosine kinase from rabbit liver. II. Substrate and inhibitor specificity. J Biol Chem (1979) 1.35
Molecular analysis of two fructokinases involved in sucrose metabolism of enteric bacteria. Mol Microbiol (1991) 1.35
Adenosine metabolism in phytohemagglutinin-stimulated human lymphocytes. J Clin Invest (1976) 1.29
Nucleotide sequence and analysis of the Vibrio alginolyticus sucrose uptake-encoding region. Gene (1990) 1.16
Primary structure and characterization of a cDNA clone of fructokinase from potato (Solanum tuberosum L. cv record). Plant Physiol (1993) 1.14
Substrate specificity of mitochondrial 2'-deoxyguanosine kinase. Efficient phosphorylation of 2-chlorodeoxyadenosine. J Biol Chem (1993) 1.12
Sequence similarities between the gene specifying 1-phosphofructokinase (fruK), genes specifying other kinases in Escherichia coli K12, and lacC of Staphylococcus aureus. Proc Biol Sci (1990) 1.09
Cloning and expression of human deoxycytidine kinase cDNA. Proc Natl Acad Sci U S A (1991) 1.09
Adenosine kinase from rabbit liver. I. Purification by affinity chromatography and properties. J Biol Chem (1979) 1.07
Isolation and characterization of adenosine kinase from Leishmania donovani. J Biol Chem (1987) 1.06
Adenosine kinase from human erythrocytes: kinetic studies and characterization of adenosine binding sites. Biochemistry (1987) 1.02
Purinergic modulation of T-lymphocyte activation: differential susceptibility of distinct activation steps and correlation with intracellular 3',5'-cyclic adenosine monophosphate accumulation. Cell Immunol (1986) 1.00
Purification and properties of human placental adenosine kinase. J Biol Chem (1979) 0.98
Identification of the mechanism of activation of 9-beta-D-arabinofuranosyladenine in human lymphoid cells using mutants deficient in nucleoside kinases. Cancer Res (1981) 0.95
Protective effect of an adenosine kinase inhibitor in septic shock. J Immunol (1994) 0.94
Molecular mechanism of methotrexate action in inflammation. Inflammation (1992) 0.93
Inhibition of lymphocyte-mediated cytolysis by adenosine analogs. Biochemical studies concerning mechanism of action. Biochem Pharmacol (1978) 0.92
Anti-inflammatory effects of an adenosine kinase inhibitor. Decreased neutrophil accumulation and vascular leakage. J Immunol (1995) 0.91
Adenosine kinase from human liver. Biochim Biophys Acta (1981) 0.91
Regulation of deoxyadenosine and nucleoside analog phosphorylation by human placental adenosine kinase. J Biol Chem (1985) 0.89
Kinetic considerations for the regulation of adenosine and deoxyadenosine metabolism in mouse and human tissues based on a thymocyte model. Biochim Biophys Acta (1982) 0.87
Properties of a highly purified mitochondrial deoxyguanosine kinase. Arch Biochem Biophys (1988) 0.85
Role of adenylate cyclase in human T-lymphocyte surface antigen capping. Cell Immunol (1986) 0.84
Adenosine kinase from L1210 cells. Purification and some properties of the enzyme. J Biol Chem (1980) 0.84
Structural requirements for activity of nucleosides as substrates for adenosine kinase: orientation of substituents on the pentofuranosyl ring. Mol Pharmacol (1975) 0.83
Human T-lymphoblast deoxycytidine kinase: purification and properties. Biochemistry (1989) 0.83
Differential inhibition of lymphocyte function by 2-chloroadenosine. Int J Immunopharmacol (1984) 0.80
RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell (1992) 17.50
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (1994) 6.06
Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study. Diabetologia (2011) 5.62
Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study. Osteoporos Int (2012) 4.09
The use of proteolytic enzymes to improve immunoglobulin staining by the PAP technique. Histochem J (1979) 4.06
Secular trends in the prevalence of diabetes and impaired glucose tolerance in urban South India--the Chennai Urban Rural Epidemiology Study (CURES-17). Diabetologia (2006) 3.35
Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing Neisseria gonorrhoeae. N Engl J Med (1987) 2.70
Prevalence, awareness and control of hypertension in Chennai--The Chennai Urban Rural Epidemiology Study (CURES-52). J Assoc Physicians India (2007) 2.53
The role of adenosine and 2'-deoxyadenosine in mammalian cells. Annu Rev Biochem (1978) 2.49
A simplified Indian Diabetes Risk Score for screening for undiagnosed diabetic subjects. J Assoc Physicians India (2005) 2.32
The need for obtaining accurate nationwide estimates of diabetes prevalence in India - rationale for a national study on diabetes. Indian J Med Res (2011) 2.26
Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev (2007) 2.24
Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum (2000) 2.13
Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity. J Allergy Clin Immunol (2000) 2.05
Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells. Proc Natl Acad Sci U S A (1978) 1.93
Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice. Diabetes (1987) 1.86
Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism. Nat Biotechnol (2000) 1.76
Inhibition of TNF-alpha expression by adenosine: role of A3 adenosine receptors. J Immunol (1996) 1.75
Isolation of tubercle bacilli from sputum samples of patients in the field studies by the cetylpyridinium chloride-sodium chloride & sodium hydroxide methods. Indian J Med Res (1995) 1.71
Studies on the mechanism of fructose-induced hyperuricemia in man. Metabolism (1972) 1.67
Cyclosporine-induced hyperuricemia and gout. N Engl J Med (1989) 1.67
Ethanol-induced hyperuricemia: evidence for increased urate production by activation of adenine nucleotide turnover. N Engl J Med (1982) 1.64
The pentafunctional FAS1 gene of yeast: its nucleotide sequence and order of the catalytic domains. Mol Gen Genet (1986) 1.60
Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia. Leukemia (2011) 1.55
Guanine ribonucleotide depletion inhibits T cell activation. Mechanism of action of the immunosuppressive drug mizoribine. J Clin Invest (1991) 1.55
Acromegalic arthropathy. Characteristics and response to therapy. Arthritis Rheum (1988) 1.54
Lymphocyte ecto-5'-nucleotidase deficiency in agammaglobulinemia. Science (1978) 1.53
Retracted DNA-PKcs is required for activation of innate immunity by immunostimulatory DNA. Cell (2000) 1.49
Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. N Engl J Med (1981) 1.48
Neonatal adrenoleukodystrophy: new cases, biochemical studies, and differentiation from Zellweger and related peroxisomal polydystrophy syndromes. Am J Med Genet (1986) 1.47
The self-pith. AJNR Am J Neuroradiol (2007) 1.44
Purine metabolism during strenuous muscular exercise in man. Metabolism (1980) 1.44
Regulation of the human inosine monophosphate dehydrogenase type I gene. Utilization of alternative promoters. J Biol Chem (1997) 1.42
Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine. J Clin Oncol (2002) 1.42
Human phosphoribosylpyrophosphate synthetase. Distribution, purification, and properties. J Biol Chem (1971) 1.38
Association of terminal deoxynucleotidyl transferase with Ku. Proc Natl Acad Sci U S A (1999) 1.36
Human phosphoribosylpyrophosphate synthetase. Kinetic mechanism and end product inhibition. J Biol Chem (1972) 1.36
Metabolic basis for disorders of purine nucleotide degradation. Metabolism (1981) 1.36
C-myc overexpression and p53 loss cooperate to promote genomic instability. Oncogene (1999) 1.34
Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies. J Clin Oncol (2005) 1.32
Structural analysis of the deoxycytidine kinase gene in patients with acute myeloid leukemia and resistance to cytosine arabinoside. Leukemia (1994) 1.32
Purine nucleoside phosphorylase. 1. Structure-function studies. Biochemistry (1997) 1.30
Precision top-quark mass measurement at CDF. Phys Rev Lett (2012) 1.30
Risk of development of tuberculosis in HIV-infected patients. Int J Tuberc Lung Dis (2000) 1.28
Biochemical basis for differential deoxyadenosine toxicity to T and B lymphoblasts: role for 5'-nucleotidase. Proc Natl Acad Sci U S A (1979) 1.28
Phosphoribosylpyrophosphate in man: biochemical and clinical significance. Ann Intern Med (1971) 1.28
A continuous spectrophotometric assay for glycosyltransferases. Anal Biochem (1994) 1.25
Conjugation of protein to immunostimulatory DNA results in a rapid, long-lasting and potent induction of cell-mediated and humoral immunity. Eur J Immunol (2000) 1.24
Measurement of the cross section for prompt isolated diphoton production using the full CDF run II data sample. Phys Rev Lett (2013) 1.22
Deficiency of enzymes catalyzing the biosynthesis of glycerol-ether lipids in Zellweger syndrome. A new category of metabolic disease involving the absence of peroxisomes. N Engl J Med (1984) 1.22
Inverse regulation of cyclin B1 by c-Myc and p53 and induction of tetraploidy by cyclin B1 overexpression. Cancer Res (2001) 1.22
Tumor uptake and elimination of 2',2'-difluoro-2'-deoxycytidine (gemcitabine) after deoxycytidine kinase gene transfer: correlation with in vivo tumor response. Clin Cancer Res (2001) 1.22
Rat mammary gland fatty acid synthase: localization of the constituent domains and two functional polyadenylation/termination signals in the cDNA. Nucleic Acids Res (1989) 1.22
Inhibition of purine nucleoside phosphorylase by 8-aminoguanosine: selective toxicity for T lymphoblasts. Science (1981) 1.21
Hyperuricemia: a marker for cell energy crisis. N Engl J Med (1987) 1.21
Enhancement of innate immunity against Mycobacterium avium infection by immunostimulatory DNA is mediated by indoleamine 2,3-dioxygenase. Infect Immun (2001) 1.21
Mortality rates due to diabetes in a selected urban south Indian population--the Chennai Urban Population Study [CUPS--16]. J Assoc Physicians India (2006) 1.19
The impact of lymphatic filariasis on labour inputs in southern India: results of a multi-site study. Ann Trop Med Parasitol (2000) 1.19
A diabetes risk score helps identify metabolic syndrome and cardiovascular risk in Indians - the Chennai Urban Rural Epidemiology Study (CURES-38). Diabetes Obes Metab (2007) 1.17
Zellweger syndrome: biochemical and morphological studies on two patients treated with clofibrate. Pediatr Res (1985) 1.16
Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment. Ann Rheum Dis (2001) 1.15
Effects of guanine nucleotide depletion on cell cycle progression in human T lymphocytes. Blood (1998) 1.14
T cells, but not B cells, are required for bowel inflammation in interleukin 2-deficient mice. J Exp Med (1995) 1.14
Genomic cloning of methylthioadenosine phosphorylase: a purine metabolic enzyme deficient in multiple different cancers. Proc Natl Acad Sci U S A (1996) 1.14
Using MR angiography for surgical planning in pelvic kidney renal cell carcinoma. AJR Am J Roentgenol (2001) 1.13
A novel POU homeodomain gene specifically expressed in cells of the developing mammalian nervous system. Nucleic Acids Res (1992) 1.12
Seroprevalence of human immunodeficiency virus (HIV) infection among tuberculosis patients in Tamil Nadu. Indian J Med Res (2003) 1.12
Measurement of the WW + WZ production cross section using the lepton + jets final state at CDF II. Phys Rev Lett (2010) 1.12
Localisation of immunoglobulin (IgG) within the rat metrial gland. J Reprod Immunol (1980) 1.11
First observation of the decay Bs0-->Ds-Ds+ and measurement of its branching ratio. Phys Rev Lett (2008) 1.11
High Km soluble 5'-nucleotidase from human placenta. Properties and allosteric regulation by IMP and ATP. J Biol Chem (1988) 1.10
Recombinant human inosine monophosphate dehydrogenase type I and type II proteins. Purification and characterization of inhibitor binding. Biochem Pharmacol (1995) 1.10
Selective reduction and recovery of invariant Valpha24JalphaQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus. J Rheumatol (2001) 1.10
CD11c (LEU-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia. Blood (1990) 1.10
Cloning and expression of human deoxycytidine kinase cDNA. Proc Natl Acad Sci U S A (1991) 1.09
Ethanol-induced activation of adenine nucleotide turnover. Evidence for a role of acetate. J Clin Invest (1984) 1.09
Inosine-5'-monophosphate dehydrogenase: regulation of expression and role in cellular proliferation and T lymphocyte activation. Prog Nucleic Acid Res Mol Biol (1998) 1.09
Resistance to 1-beta-D-arabinofuranosylcytosine in human T-lymphoblasts mediated by mutations within the deoxycytidine kinase gene. Cancer Res (1992) 1.09
Evidence for a particle produced in association with weak bosons and decaying to a bottom-antibottom quark pair in higgs boson searches at the tevatron. Phys Rev Lett (2012) 1.08
Human hypoxanthine-guanine phosphoribosyltransferase. J Biol Chem (1983) 1.07
Measurement of sigma chi c2 B(chi c2-->J/psi gamma)/sigma chi c1 B(chi c1 -->J/psi gamma) in pp collisions at square root s=1.96 TeV. Phys Rev Lett (2007) 1.07
Precise measurement of the W-boson mass with the CDF II detector. Phys Rev Lett (2012) 1.06
Compound GW506U78 in refractory hematologic malignancies: relationship between cellular pharmacokinetics and clinical response. J Clin Oncol (1998) 1.06
Association of physical inactivity with components of metabolic syndrome and coronary artery disease--the Chennai Urban Population Study (CUPS no. 15). Diabet Med (2005) 1.06
Purine nucleoside phosphorylase. 3. Reversal of purine base specificity by site-directed mutagenesis. Biochemistry (1997) 1.05
Depletion of erythrocyte phosphoribosylpyrophosphate in man. N Engl J Med (1970) 1.05
Hyperuricemia and hypertriglyceridemia: metabolic basis for the association. Metabolism (1985) 1.04
Human placental adenosine kinase. Kinetic mechanism and inhibition. J Biol Chem (1980) 1.04
ATP depletion as a consequence of adenosine deaminase inhibition in man. Proc Natl Acad Sci U S A (1980) 1.04
Ethics of HIV trials. Lancet (1997) 1.04
Direct measurement of the W production charge asymmetry in pp collisions at square root s=1.96 TeV. Phys Rev Lett (2009) 1.04
Search for long-lived massive charged particles in 1.96 TeV pp collisions. Phys Rev Lett (2009) 1.03
Distribution of 5'-nucleotidase in human lymphoid tissues. Proc Natl Acad Sci U S A (1979) 1.03
An improved composition for embalming fluid to preserve cadavers for anatomy teaching in the United Kingdom. J Anat (1993) 1.01
Ascorbic acid-induced uricosuria. A consequency of megavitamin therapy. Ann Intern Med (1976) 1.01
Pseudomonas aeruginosa II lectin stops human ciliary beating: therapeutic implications of fucose. Am J Respir Crit Care Med (1997) 1.01
Inhibition of T lymphocyte activation in mice heterozygous for loss of the IMPDH II gene. J Clin Invest (2000) 1.01